Integrating immunopeptidomics with liquid biopsy for precision oncology
{{output}}
In cancer immunotherapy, peptide-major histocompatibility complexes are increasingly exploited as precise therapeutic targets. For instance, T-cell receptor (TCR)-engineered T cells, peptide vaccines, and TCR-mimic antibodies leverage the direct recognition of... ...
